Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.09 +0.19 (+10.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Foghorn Therapeutics (FHTX) Selling, General & Administrative (2019 - 2026)

Updated

Foghorn Therapeutics (FHTX) posted Selling, General & Administrative of $6.35 million for Q2 2026, down 7.4% from $6.86 million a year earlier and down 3.4% from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Selling, General & Administrative (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Foghorn Therapeutics was $26.38 million, down 3.8% year-over-year; for FY2025, it came in at $27.55 million, down 2.9% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 19.6% (FY2020 to FY2025).
  • In prior years, Foghorn Therapeutics' Selling, General & Administrative was $28.36 million in FY2024 (-12.4%), $32.37 million in FY2023 (+5.3%), $30.75 million in FY2022 (+41.5%) and $21.73 million in FY2021 (+93.2%).
  • The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q4 2024.
  • On a year-over-year basis, Selling, General & Administrative increased in 1 of the last eight quarters, with an average decline of 6.5%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 127.3%; the weakest was Q3 2024, with a decline of 16.1%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $6.58 million (Q1 2026), $6.8 million (Q4 2025) and $6.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Foghorn Therapeutics 113.93 Mn -202.99 Mn - 5.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.80 Mn
Jun 30, 2026 6.35 Mn
Mar 31, 2026 6.58 Mn
Dec 31, 2025 6.80 Mn
Sep 30, 2025 6.65 Mn
Jun 30, 2025 6.86 Mn
Mar 31, 2025 7.24 Mn
Dec 31, 2024 6.35 Mn
Sep 30, 2024 6.97 Mn
Jun 30, 2024 7.33 Mn
Mar 31, 2024 7.71 Mn
Dec 31, 2023 7.02 Mn
Sep 30, 2023 8.31 Mn
Jun 30, 2023 8.40 Mn
Mar 31, 2023 8.64 Mn
Dec 31, 2022 7.86 Mn
Sep 30, 2022 7.97 Mn
Jun 30, 2022 7.70 Mn
Mar 31, 2022 7.22 Mn
Dec 31, 2021 6.33 Mn
API Access

Foghorn Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=FHTX&period=max&api_key=YOUR_API_KEY